The Monoamine Oxidase-B Inhibitor Selegiline Does Not Affect 18F-Florzolotau Uptake in Patients with Progressive Supranuclear Palsy: A Longitudinal Case Series

for the Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI)

Research output: Contribution to journalJournal Letter peer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)705-707
Number of pages3
JournalMovement Disorders
Volume38
Issue number4
DOIs
StatePublished - 04 2023

Keywords

  • F-Florzolotau
  • monoamine oxidase B
  • positron emission tomography
  • selegiline
  • tau
  • Supranuclear Palsy, Progressive/drug therapy
  • Monoamine Oxidase Inhibitors/pharmacology
  • Selegiline/pharmacology
  • Humans
  • Positron-Emission Tomography
  • Monoamine Oxidase
  • tau Proteins

Cite this